C44.122 is a non-specific and non-billable ICD-10 code code, consider using a code with a higher level of specificity for a diagnosis of squamous cell carcinoma of skin of right eyelid, including canthus. The code is not specific and is NOT valid for the year 2023 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
The following anatomical sites found in the Table of Neoplasms reference the parent code C44.12 of the current diagnosis code given the correct histological behavior: Neoplasm, neoplastic canthus (eye) (inner) (outer) squamous cell carcinoma ; Neoplasm, neoplastic eyelid (lower) (skin) (upper) squamous cell carcinoma ; Neoplasm, neoplastic lid (lower) (upper) squamous cell carcinoma ; Neoplasm, neoplastic meibomian gland squamous cell carcinoma ; Neoplasm, neoplastic palpebra squamous cell carcinoma ; Neoplasm, neoplastic skin NOS canthus (eye) (inner) (outer) squamous cell carcinoma ; Neoplasm, neoplastic skin NOS eyelid squamous cell carcinoma ; etc
Specific Coding for Squamous cell carcinoma skin/ right eyelid, inc canthus
Non-specific codes like C44.122 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for squamous cell carcinoma skin/ right eyelid, inc canthus:
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|C44.122||173.12 - Squam cell ca lid/canth|
|Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.|
Table of Neoplasms
The parent code C44.12 of the current diagnosis code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Your eyelids help protect your eyes. When you blink, your eyelids spread moisture over your eyes. Blinking also helps move dirt or other particles off the surface of the eye. You close your eyelids when you see something coming toward your eyes. This can help protect against injuries.
Like most other parts of your body, your eyelids can get infected, inflamed, or even develop cancer. There are also specific eyelid problems, including:
- Eyelids that turn in or out
- Eyelids that droop
- Abnormal blinking or twitching
Treatment of eyelid problems depends on the cause.
[Learn More in MedlinePlus]
Skin cancer is the most common form of cancer in the United States. The two most common types are basal cell cancer and squamous cell cancer. They usually form on the head, face, neck, hands, and arms. Another type of skin cancer, melanoma, is more dangerous but less common.
Anyone can get skin cancer, but it is more common in people who :
- Spend a lot of time in the sun or have been sunburned
- Have light-colored skin, hair and eyes
- Have a family member with skin cancer
- Are over age 50
You should have your doctor check any suspicious skin markings and any changes in the way your skin looks. Treatment is more likely to work well when cancer is found early. If not treated, some types of skin cancer cells can spread to other tissues and organs. Treatments include surgery, radiation therapy, chemotherapy, photodynamic therapy (PDT), and biologic therapy. PDT uses a drug and a type of laser light to kill cancer cells. Biologic therapy boosts your body's own ability to fight cancer.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)